Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor

[1]  E. Diamandis,et al.  Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. , 2010, Endocrinology.

[2]  J. Jensen,et al.  The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart. , 2009, Pharmacological research.

[3]  J. Pernow,et al.  Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo , 2009, Regulatory Peptides.

[4]  A. Curcio,et al.  Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85alphaPI3K. , 2009, American journal of physiology. Heart and circulatory physiology.

[5]  B. Trimarco,et al.  Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[6]  T. Nyström,et al.  The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[7]  K. Sunagawa,et al.  Vascular Endothelial Growth Factor Receptor-1 Regulates Postnatal Angiogenesis Through Inhibition of the Excessive Activation of Akt , 2008, Circulation research.

[8]  D. Drucker,et al.  Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways , 2008, Circulation.

[9]  J. Juengel,et al.  The cooperative effect of growth and differentiation factor-9 and bone morphogenetic protein (BMP)-15 on granulosa cell function is modulated primarily through BMP receptor II. , 2008, Endocrinology.

[10]  S. Glaser,et al.  Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. , 2007, Gastroenterology.

[11]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[12]  Nick D. Tsihlis,et al.  The role of nitric oxide in the pathophysiology of intimal hyperplasia. , 2007, Journal of vascular surgery.

[13]  B. Wajchenberg.  beta-cell failure in diabetes and preservation by clinical treatment. , 2007, Endocrine reviews.

[14]  D. Power,et al.  Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. , 2007, Journal of molecular and cellular cardiology.

[15]  G. King,et al.  Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[16]  U. Kayisli,et al.  Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating Fas and Fas ligand expression. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  D. Drucker,et al.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes , 2006, The Lancet.

[18]  R. Meidan,et al.  Inverse relationship between nitric oxide synthases and endothelin-1 synthesis in bovine corpus luteum: interactions at the level of luteal endothelial cell. , 2006, Endocrinology.

[19]  A. Tengholm,et al.  Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion. , 2006, American journal of physiology. Cell physiology.

[20]  A. Flyvbjerg,et al.  Prevention and early detection of vascular complications of diabetes , 2006, BMJ : British Medical Journal.

[21]  T. Hintze,et al.  cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. , 2006, American journal of physiology. Heart and circulatory physiology.

[22]  D. Accili,et al.  Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic β-Cell Mass , 2006, Diabetes.

[23]  U. Förstermann,et al.  Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.

[24]  R. Busse,et al.  Gab1, SHP2, and Protein Kinase A Are Crucial for the Activation of the Endothelial NO Synthase by Fluid Shear Stress , 2005, Circulation research.

[25]  J. Balligand,et al.  Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. , 2005, Pharmacology & therapeutics.

[26]  R. Shannon,et al.  Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. , 2005, American journal of physiology. Heart and circulatory physiology.

[27]  N. Hay,et al.  Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo , 2005, Nature Medicine.

[28]  J. Holst,et al.  Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. , 2004, American journal of physiology. Endocrinology and metabolism.

[29]  R. Bowler,et al.  Colocalization of eNOS and the Catalytic Subunit of PKA in Endothelial Cell Junctions: A Clue for Regulated NO Production , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  J. Habener,et al.  Glucagon-like peptide 1 agonists and the development and growth of pancreatic β-cells , 2004 .

[31]  D. Drucker,et al.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. , 2004, Endocrinology.

[32]  B. Hemmings,et al.  Physiological functions of protein kinase B/Akt. , 2004, Biochemical Society transactions.

[33]  J. Kondapalli,et al.  Laminar Shear Stress Differentially Modulates Gene Expression of p120 Catenin, Kaiso Transcription Factor, and Vascular Endothelial Cadherin in Human Coronary Artery Endothelial Cells* , 2004, Journal of Biological Chemistry.

[34]  C. Rhodes,et al.  Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells , 2004, Diabetologia.

[35]  Jianxin Sun,et al.  Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase Akt Pathway Mediates Nitric Oxide-Induced Endothelial Cell Migration and Angiogenesis , 2003, Molecular and Cellular Biology.

[36]  I. Valverde,et al.  Cell signalling of the GLP-1 action in rat liver , 2003, Molecular and Cellular Endocrinology.

[37]  Hanjoong Jo,et al.  Compensatory Phosphorylation and Protein-Protein Interactions Revealed by Loss of Function and Gain of Function Mutants of Multiple Serine Phosphorylation Sites in Endothelial Nitric-oxide Synthase* , 2003, The Journal of Biological Chemistry.

[38]  R. Perfetti,et al.  Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. , 2003, Endocrinology.

[39]  D. D’Alessio,et al.  Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. , 2003, The Journal of clinical endocrinology and metabolism.

[40]  I. Idris,et al.  Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1. , 2002, Biochemical pharmacology.

[41]  M. Quon,et al.  Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[42]  J. Abe,et al.  Endothelial Atheroprotective and Anti‐inflammatory Mechanisms , 2001, Annals of the New York Academy of Sciences.

[43]  R. Busse,et al.  Phosphorylation of Thr495 Regulates Ca2+/Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity , 2001 .

[44]  D. Power,et al.  Coordinated Control of Endothelial Nitric-oxide Synthase Phosphorylation by Protein Kinase C and the cAMP-dependent Protein Kinase* , 2001, The Journal of Biological Chemistry.

[45]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[46]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[47]  J. Callés-Escandon,et al.  Diabetes and endothelial dysfunction: a clinical perspective. , 2001, Endocrine reviews.

[48]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[49]  D. Hörsch,et al.  Integrative Mitogenic Role of Protein Kinase B/Akt in β‐Cells , 2000 .

[50]  H. Schmidt,et al.  Endothelial Nitric-oxide Synthase (Type III) Is Activated and Becomes Calcium Independent upon Phosphorylation by Cyclic Nucleotide-dependent Protein Kinases* , 2000, The Journal of Biological Chemistry.

[51]  P. Vogt,et al.  Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  A. Zeiher,et al.  Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[53]  S. Bonner-Weir,et al.  Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. , 1999, Diabetes.

[54]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[55]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[56]  J. Loscalzo,et al.  Endothelial function and atherosclerosis. , 1999, Coronary artery disease.

[57]  M. Prentki,et al.  Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells , 1999, Diabetologia.

[58]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[59]  J. Mehta,et al.  Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. , 1998, American journal of physiology. Heart and circulatory physiology.

[60]  T. Irimura,et al.  Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diaminofluoresceins , 1998, FEBS letters.

[61]  R. D. Rudic,et al.  Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.

[62]  L. B. Knudsen,et al.  Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor. , 1996, European journal of pharmacology.

[63]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[64]  R. Abraham,et al.  Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002. , 1996, The EMBO journal.

[65]  H. Granger,et al.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.

[66]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[67]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  G. Kojda,et al.  Effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate in experimental atherosclerosis. , 1995, Agents and actions. Supplements.

[69]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[70]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[71]  E. Garvey,et al.  Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. , 1993, Biochemistry.

[72]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[73]  C. J. Schwartz,et al.  Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. , 1973, Atherosclerosis.